CJ MedTech and DePuy Synthes Hold Seminar to Share Fracture Treatment Strategies

Over 40 Medical Professionals from Gwangju and Jeonnam Attend

CJ MedTech announced on the 29th that, together with global medical device company DePuy Synthes, it held a 'Meet the Expert' seminar on the 3rd at the Holiday Inn Hotel in Gwangju for orthopedic medical professionals in the Gwangju and Jeonnam regions.

This seminar was organized to bring together domestic experts in fracture and trauma treatment to share the latest clinical experiences and real-world applications of rhBMP-2-based bone regeneration therapies, and to discuss a variety of treatment strategies for fractures and bone defects. Over 40 orthopedic specialists in fracture and trauma treatment from the Gwangju and Jeonnam regions attended the event.

Sygimedtech and DePuy Synthes held a 'Meet the Expert (Trauma & rhBMP-2)' seminar on the 3rd at the Holiday Inn Hotel in Gwangju for orthopedic medical staff in the Gwangju and Jeonnam regions. Sygimedtech

The seminar was chaired by Professor Oh Jonggeon of Korea University Guro Hospital and Professor Lee Junyoung of Chosun University Hospital. Medical professionals who participated as speakers shared a range of clinical experiences using Novosis Trauma. Novosis is a bone regeneration medical device that combines a hydroxyapatite (HAp)-based ceramic carrier with recombinant human bone morphogenetic protein-2 (rhBMP-2).

Professor Lee Gwangcheol of Chosun University Hospital presented his clinical experiences and outcomes in treating various bone defects, including the Masquelet technique. Professor Lee Gunwoo of Chonnam National University Hospital introduced treatment strategies using Novosis Trauma as a biological adjunct therapy for peri-prosthetic cysts and complicated foot and ankle fusions. Professor Kwon Taeyoung of Chonbuk National University Hospital shared his clinical experience applying the device in various traumatic bone disorders, including long bone nonunion and subtrochanteric femur fractures.

You Hyunseung, CEO of CJ MedTech, stated, "We will continue to closely cooperate with DePuy Synthes, consistently accumulating evidence-based clinical data and expanding medical education and academic exchange to contribute to the advancement of trauma treatment both domestically and internationally."

This content was produced with the assistance of AI translation services.